Migraine Management in Japan: Current Approaches and Science Narrative Including an Evidence-based Review

Takao Takeshima; Shoji Kikui; Daisuke Danno

doi:10.2169/internalmedicine.4846-24

Internal Medicine

Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918

Migraine Management in Japan: Current Approaches and Science Narrative Including an Evidence-based Review

Takao Takeshima, Shoji Kikui, Daisuke Danno

Author information

Keywords: pharmacotherapy, calcitonin gene-related peptide (CGRP), neuromodulation

JOURNAL OPEN ACCESS Advance online publication

Article ID: 4846-24

DOI https://doi.org/10.2169/internalmedicine.4846-24

Details

Abstract

Migraine is a prevalent and highly disabling neurological disorder. Recent progress in neuroscientific research has contributed to the development of new therapies for migraine, including triptans, ditans, calcitonin gene-related peptide (CGRP) antagonists, and CGRP-related monoclonal antibodies. Noninvasive neuromodulation devices have also been developed. We herein review the recent advances in research and the current standard of management for migraine patients.

Content from these authors

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/

Favorites & Alerts

Corresponding author

Register with J-STAGE for free!